
Sign up to save your podcasts
Or


Health care accessibility and drug affordability have been long-standing issues in the U.S., with some studies showing that approximately 1 in 3 Americans struggle to afford prescription drugs.
Patients for Affordable Drugs, or P4AD, is a national patient organization focused on advocating for lower prescription drug prices in the U.S. In this episode, editors Vincent De Luca, Faye Nikolettos, and Samuel Lee Ribeiro Toi interview Merith Basey, Executive Director of P4AD, and Michael Lieberman, a lawyer for the organization and a graduate of Harvard Law School.
Our discussion explores the organization's recent legal successes in advocating for affordable drugs, the impact of recent tariffs on the issue, as well as potential policy and legislative changes that can help improve access to medicines. This episode delves into the realities of the American privatized healthcare system while simultaneously highlighting effective patient advocacy in the legal field.
By McGill Journal of Law and HealthHealth care accessibility and drug affordability have been long-standing issues in the U.S., with some studies showing that approximately 1 in 3 Americans struggle to afford prescription drugs.
Patients for Affordable Drugs, or P4AD, is a national patient organization focused on advocating for lower prescription drug prices in the U.S. In this episode, editors Vincent De Luca, Faye Nikolettos, and Samuel Lee Ribeiro Toi interview Merith Basey, Executive Director of P4AD, and Michael Lieberman, a lawyer for the organization and a graduate of Harvard Law School.
Our discussion explores the organization's recent legal successes in advocating for affordable drugs, the impact of recent tariffs on the issue, as well as potential policy and legislative changes that can help improve access to medicines. This episode delves into the realities of the American privatized healthcare system while simultaneously highlighting effective patient advocacy in the legal field.